2 chapters across the catalog
The emergence of FluMist, a nasal spray vaccine, is discussed in the context of the FDA's recent ban on Zycam. The hosts suggest that Zycam was removed from the market to eliminate competition for the new nasal vaccine delivery method. They also question why the seasonal flu vaccine was released unusually early in September this year.
A personal anecdote regarding a head cold leads to a discussion about Zycam, a zinc-based cold remedy. While acknowledging skepticism regarding its effectiveness as a potential placebo, one speaker claims it successfully prevents colds when used at the first sign of symptoms. The conversation includes a humorous pitch for a hypothetical sponsorship based on "blasting nose holes" with the product.
